2023 Inherited Retinal Disease Research Updates
September is Inherited Retinal Disease (IRD) Month and we thought it was a great time to share some of the research discoveries that are moving us towards new treatments across different IRDs…
VIEW POINT RECORDINGS
Jump to: AMD | Cataracts | Glaucoma | IRDs and Genetics | Diabetes | Innovative Treatments | FBC Research Awardees | Year in Review and Town Hall | Living Well with Vision Loss | Community Showcase Ffind all of our past webinars on our View Point YouTube Playlist. AGE-RELATED MACULAR DEGENERATION (AMD)…
$1.67 million for transformative research into retinal degeneration
These two awards will fund projects at the forefront of research into glaucoma and inherited retinal diseases. For nearly 50 years, Fighting Blindness Canada has helped move the needle on vision research,…
Canadians now have access to Luxturna!
Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by…
Advances in Stem Cell Therapy made by FBC-Funded Researcher
Cells Grown in Lab can Reach Out and Connect to Other Retina Cells Fighting Blindness Canada (FBC) funded scientist Dr. David Gamm (University of Wisconsin) has successfully shown that photoreceptor cells grown…
top 10 articles that Captured Your Attention in 2022!
Funding innovative vision research is at the heart of Fighting Blindness Canada (FBC). Throughout the year, our monthly e-newsletter has shared articles and publications showcasing the amazing research and advocacy work taking…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.